Загрузка...
Spironolactone Treatment and Effect on Survival in Chronic Heart Failure Patients with Reduced Renal Function: A Propensity-Matched Study
BACKGROUND/AIMS: Spironolactone may be hazardous in heart failure (HF) patients with renal dysfunction due to risk of hyperkalemia and worsened renal function. We aimed to evaluate the effect of spironolactone on all-cause mortality in HF outpatients with renal dysfunction in a propensity-score-matc...
Сохранить в:
| Опубликовано в: : | Cardiorenal Med |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
S. Karger AG
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5465786/ https://ncbi.nlm.nih.gov/pubmed/28611786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000454933 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|